Ovarian Hyperstimulation Syndrome: Clinical Trials

61 trials for Ovarian Hyperstimulation Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 19 unknown, 6 terminated, 3 withdrawn. 17 Not applicable, 15 Phase 4, 7 Phase 2, 7 Phase 3, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable17Unknown 7, Completed 6, Withdrawn 3, Terminated 1
Phase 415Completed 7, Unknown 5, Terminated 3
Phase 27Completed 5, Suspended 1, Unknown 1
Phase 37Completed 4, Unknown 3
Early Phase 12Completed 2
Phase 12Completed 2

Follow Ovarian Hyperstimulation Syndrome: new trials by email Literature Review of Ovarian Hyperstimulation Syndrome trials Research Report on Ovarian Hyperstimulation Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myo-Inositol for Ovarian Stimulation and ICSI Outcomes in Women With PCOS
Myo-Inositol, Folic Acid - Polycystic Ovary Syndrome
Not applicableCompletedKafrelsheikh University882024-05-152026-08-21
The Letrozole Administration During Luteal Phase
Letrozole, Polygeline, Sodium Chloride - Ovarian Hyperstimulation Syndrome
Phase 3UnknownThe Affiliated Hospital of Inner Mongolia Medical University502023-12-012023-07-20
Comparative Study Between Calcium Gluconate With Diosmin, Cabergoline and Cabergoline With Diosmin
Calcium Gluconate - Ovarian Hyperstimulation Syndrome
Not applicableCompletedMinia University1802022-10-012025-01-07
Ovarian Hyperstimulation Syndrome Using Calcium Infusion
Calcium intravenous infsuion, 0.9 % saline - Ovarian Hyperstimulation Syndrome
Not applicableUnknownAl-Azhar University2002022-03-012022-02-22
Real-world Evidence on Follitropin Delta Individual Dosing
Follitropin delta - Infertility, Sterility
RecruitingUniversity of Luebeck8502021-12-082025-03-30
Association Between Live Birth Rate and Serum Progesterone During Hormonal Replacement Therapy
Identification of predictive factors - Ovarian Hyperstimulation Syndrome, Frozen-thawed Embryo Transfers
CompletedCentre Hospitalier Régional Metz-Thionville1682019-11-012022-10-20
Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS
Gonadotropin, Antagonist - Ovarian Hyperstimulation Syndrome
Phase 4CompletedClinAmygate3002019-07-012019-11-21
Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome
Pregnyl (1,500) IU, 1.5 mL of normal saline - Ovarian Hyperstimulation Syndrome, Infertility, Female
Phase 4UnknownMount Sinai Hospital, Canada802019-05-012023-07-03
Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response
Fludrocortisone 0.1 Milligrams (mg), Bromocriptine - Ovarian Hyperstimulation Syndrome
Phase 2CompletedGanin Fertility Center1072019-04-012020-04-17
Montelukast for Prevention & Treatment of OHSS
dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days - Ovarian Hyperstimulation Syndrome
Phase 2SuspendedBenha University202018-12-052022-09-21
Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders
Synarel, 0.2 Mg/Inh Nasal Spray, Estrofem, Utrogestan - Pregnancy Early, Miscarriage
Phase 4UnknownAssaf-Harofeh Medical Center1002017-12-292021-04-01
The Influence of Timing of Cabergoline Initiation on Prevention of OHSS
Late Cabergoline 0.5mg, Early Cabergoline 0.5mg - Ovarian Hyperstimulation Syndrome
Phase 3UnknownMona M Shaban752017-12-202018-04-10
Comparison of Clinical Outcomes Between IVM and Minimal Stimulation IVF in Patients With PCOS
IVM, Minimal stimulation IVF - No Condition
Not applicableUnknownCHA University2402017-05-012020-03-24
Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET
Triptorelin for Injection, Recombinant Human Choriogonadotropin alfa Solution for Injection, Progesterone Soft Capsules - Ovarian Hyperstimulation Syndrome
Phase 3UnknownChangchun GeneScience Pharmaceutical Co., Ltd.2522017-03-012017-03-06
Preventive Application of GnRH Antagonist on Early OHSS
GnRH antagonist, aspirin - Ovarian Hyperstimulation Syndrome, GnRH Antagonist
Phase 4UnknownFirst Affiliated Hospital, Sun Yat-Sen University1752017-01-012017-06-15
The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome
Minimal ovarian stimulation - Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome
Not applicableCompletedRoyan Institute1202016-11-122021-04-20
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
Decapeptyl, hCG luteal support - Infertility
Not applicableUnknownMeir Medical Center502016-08-012016-07-12
Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
bromocriptine, dexamethasone - Ovarian Hyperstimulation Syndrome
Phase 2UnknownSun Yat-sen University2002016-08-012016-07-27
Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular Response
COAGO - Ovarian Hyperstimulation Syndrome, Hypercoagulability
Not applicableTerminatedUniversity Hospital, Lille12016-02-262019-10-04
Medical Assistance for the Procreation and Risk of Thrombosis.
ovarian stimulation - Ovarian Hyperstimulation Syndrome, Cardiovascular Diseases
TerminatedUniversity Hospital, Brest1292016-02-022020-07-10

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Polycystic Ovary Syndrome (12)  ·  Infertility (8)  ·  Infertility, Female (2)  ·  Abortion, Spontaneous (1)  ·  Ascites (1)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Endometriosis (1)  ·  Infertility, Male (1)  ·  Insulin Resistance (1)  ·  Primary Ovarian Insufficiency (1)  ·  Thrombophilia (1)

Broader conditions

Adnexal Diseases (61)  ·  Endocrine System Diseases (61)  ·  Female Urogenital Diseases (61)  ·  Female Urogenital Diseases and Pregnancy Complications (61)  ·  Genital Diseases (61)  ·  Genital Diseases, Female (61)  ·  Gonadal Disorders (61)  ·  Ovarian Diseases (61)  ·  Urogenital Diseases (61)  ·  Cysts (12)  ·  Neoplasms (12)  ·  Ovarian Cysts (12)  ·  Genital Diseases, Male (1)  ·  Glucose Metabolism Disorders (1)  ·  Hematologic Diseases (1)

Interventions

Triptorelin Pamoate (8)  ·  Cabergoline (7)  ·  Chorionic Gonadotropin (5)  ·  Sodium Chloride (4)  ·  cetrorelix (4)  ·  Glycoprotein Hormones, alpha Subunit (3)  ·  follitropin alfa (3)  ·  Aspirin (2)  ·  Bromocriptine (2)  ·  Dexamethasone (2)  ·  Estradiol (2)  ·  Gonadotropin-Releasing Hormone (2)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (2)  ·  Letrozole (2)  ·  Leuprolide (2)

Sponsors

Instituto Valenciano de Infertilidad, IVI VALENCIA (3)  ·  Merck KGaA, Darmstadt, Germany (3)  ·  Royan Institute (3)  ·  Chenshiling (2)  ·  Eugonia (2)  ·  Ferring Pharmaceuticals (2)  ·  First Affiliated Hospital, Sun Yat-Sen University (2)  ·  UConn Health (2)  ·  Al-Azhar University (1)  ·  Antalya IVF (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Bagcilar Training and Research Hospital (1)  ·  Benha University (1)  ·  Bioroma (1)  ·  CHA University (1)

Countries

Egypt (7)  ·  China (6)  ·  Spain (5)  ·  United States (5)  ·  France (3)  ·  Iran (3)  ·  Israel (3)  ·  Turkey (Türkiye) (3)  ·  Denmark (2)  ·  Germany (2)  ·  Greece (2)  ·  Italy (2)  ·  Belgium (1)  ·  Canada (1)  ·  Ireland (1)

Top investigators

Ashraf Moini, MD (2)  ·  Lawrence Engmann, MD (2)  ·  Marzieh Shiva, MD (2)  ·  Shi-Ling Chen, M.D., Ph.D. (2)  ·  Alfonso Bermejo, MD (1)  ·  Amir Wiser, MD (1)  ·  Antonio Pellicer, MD (1)  ·  Ariel Hourvitz (1)  ·  Assunta Iuliano, MD, PhD (1)  ·  Azar Yahyaei, M.Sc. (1)  ·  Claudio Benadiva, MD (1)  ·  Didi D Braat, Prof. MD PhD (1)

Results publications

PMID 33851429, PMID 17854523, PMID 20008886, PMID 20139430, PMID 21134950, PMID 21601197, PMID 22231013, PMID 23753114, PMID 23932181, PMID 25552412, PMID 25780518, PMID 27060174, PMID 28130435, PMID 28461237, PMID 28494798, PMID 29175067, PMID 31227286, PMID 37340371, PMID 39912435, PMID 41221041